S
Soumya Sarkar
Researcher at AIIMS, New Delhi
Publications - 13
Citations - 242
Soumya Sarkar is an academic researcher from AIIMS, New Delhi. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 3, co-authored 8 publications receiving 85 citations.
Papers
More filters
Journal ArticleDOI
Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.
TL;DR: The consequence of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with concurrent co‐infections based on the publications reported to date is detrimental.
Journal ArticleDOI
Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis.
TL;DR: CPT may be beneficial for reducing mortality, viral shedding and improving clinical conditions in COVID‐19 patients, however, further randomized control trials (RCT) are required to substantiate the safety margin, initiation, optimal dosage, titre and duration of CPT.
Journal ArticleDOI
Are the steroids a blanket solution for COVID-19? A systematic review and meta-analysis.
TL;DR: Systemic steroid therapy may not be effective for reducing mortality, duration of hospitalization, and period of viral shedding, and studies are mostly heterogeneous.
Journal ArticleDOI
Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis.
TL;DR: In this article, the authors explored the utility of platelet-to-lymphocyte count ratio (PLR) as a prognostic predictor of COVID-19 patients.
Journal ArticleDOI
The Impact of Neutrophil-Lymphocyte Count Ratio in COVID-19: A Systematic Review and Meta-Analysis.
TL;DR: In this article, the utility of baseline neutrophil-lymphocyte count ratio (NLR) as a predictive tool for mortality, disease severity in COVID-19 patients was analyzed.